Abstract
Outcome after surgical treatment has been based predominantly on objective criteria. A more global assessment is necessary which also includes patient-reported health-related quality of life. The literature concerning investigations on quality of life measurements in surgery and follow-up in colorectal cancer is reviewed. Only a few studies are published; the results are conflicting and the methodology questionable. Therefore, it is concluded that there is a strong need for further research in this field.
Keywords: Colorectal cancer surgery, quality of life assessments, follow-up
Current Cancer Therapy Reviews
Title: Quality of Life Assessments in Colorectal Cancer Surgery. A Review
Volume: 4 Issue: 4
Author(s): Per Jess
Affiliation:
Keywords: Colorectal cancer surgery, quality of life assessments, follow-up
Abstract: Outcome after surgical treatment has been based predominantly on objective criteria. A more global assessment is necessary which also includes patient-reported health-related quality of life. The literature concerning investigations on quality of life measurements in surgery and follow-up in colorectal cancer is reviewed. Only a few studies are published; the results are conflicting and the methodology questionable. Therefore, it is concluded that there is a strong need for further research in this field.
Export Options
About this article
Cite this article as:
Jess Per, Quality of Life Assessments in Colorectal Cancer Surgery. A Review, Current Cancer Therapy Reviews 2008; 4 (4) . https://dx.doi.org/10.2174/157339408786413335
DOI https://dx.doi.org/10.2174/157339408786413335 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gene Expression-Based Pharmacodynamic Biomarkers: The Beginning of a New Era in Biomarker-Driven Anti-Tumor Drug Development
Current Molecular Medicine Recent Advances in Predicting Protein Classification and Their Applications to Drug Development
Current Topics in Medicinal Chemistry In Vitro Anticancer Evaluation of Platinum(II/IV) Complexes with Diisoamyl Ester of (S,S)-ethylenediamine-N,N’-di-2-propanoic Acid
Anti-Cancer Agents in Medicinal Chemistry Molecular Profiling - An Essential Technology Enabling Personalized Medicine in Breast Cancer
Current Drug Targets MIF and CD74 - Suitability as Clinical Biomarkers
Mini-Reviews in Medicinal Chemistry Metabolite Identification in NMR-based Metabolomics
Current Metabolomics Outcome Measures Following Sonodynamic Photodynamic Therapy – A Case Series
Current Drug Therapy Recent Development in Targeting PI3K-Akt-mTOR Signaling for Anticancer Therapeutic Strategies
Anti-Cancer Agents in Medicinal Chemistry Small Molecule Toxins Targeting Tumor Receptors
Current Pharmaceutical Design Pharmacogenetics of Childhood Acute Lymphoblastic Leukemia
Current Pharmacogenomics Immunogenicity of a Multiepitope Plasmid DNA Encoding T and B Lymphocyte Epitopes from Latent Membrane Protein 2 (LMP2) of Epstein-Barr Virus as a Vaccine in Mice
Protein & Peptide Letters Inhibition of Angiogenesis as a Treatment Strategy for Neuroblastoma
Current Cancer Therapy Reviews Serpins for Diagnosis and Therapy in Cancer
Cardiovascular & Hematological Disorders-Drug Targets Signal Transduction Therapy Targeting Apoptosis Pathways in Cancers
Current Signal Transduction Therapy Fluorine-18 Labeled Amino Acids for Oncologic Imaging with Positron Emission Tomography
Current Topics in Medicinal Chemistry Novel Agents Aiming at Specific Molecular Targets Increase Chemosensitivity and Overcome Chemoresistance in Hematopoietic Malignancies
Current Pharmaceutical Design (Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) Mammalian Nucleoside Transporters
Current Drug Metabolism Crosstalk Between The Immune Receptors and Gut Microbiota
Current Protein & Peptide Science EDITORIAL [Hot topic: RAS - A Central Feature in Cancer Targeted Therapy (Guest Editor: Balazs Gyorffy)
Current Cancer Drug Targets Will Antiangiogenic Agents be a Future for Mesothelioma Therapy?
Current Medicinal Chemistry